Not applicableNot Yet RecruitingNCT06879470What this trial is testingJY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell LymphomaWho this might be right forB-Non Hodgkin Lymphoma He Huang 24
Not applicableLooking for participantsNCT06678282What this trial is testingJY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ LeukemiaWho this might be right forB-NHLB-ALL Shenzhen Genocury Biotech Co., Ltd. 20
Early research (Phase 1)Active Not RecruitingNCT02992522What this trial is testingObinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forB-Cell Lymphoma, UnspecifiedGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+10 more Beth Christian 22
Early research (Phase 1)Looking for participantsNCT06445803What this trial is testingCD19/CD22 CAR-T Cells in Adults With R/R ALL or NHLWho this might be right forAcute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed RemissionB-cell Lymphoma Refractory+1 more Rong Tao 48
Testing effectiveness (Phase 2)Study completedNCT00003270What this trial is testingChemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Roswell Park Cancer Institute 20
Not applicableActive Not RecruitingNCT02633111What this trial is testingDNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin LymphomasWho this might be right forB-cell Non-Hodgkin LymphomaAggressive Memorial Sloan Kettering Cancer Center 501
Early research (Phase 1)Study completedNCT00006098What this trial is testingPS-341 in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04205409What this trial is testingNivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic MalignanciesWho this might be right forRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+15 more University of Washington 20
Testing effectiveness (Phase 2)Looking for participantsNCT06784726What this trial is testingOdronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-TWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Grade 3b Follicular Lymphoma+9 more University of Washington 27
Testing effectiveness (Phase 2)Study completedNCT03770416What this trial is testingNivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System LymphomaWho this might be right forCentral Nervous System B-Cell Non-Hodgkin LymphomaRecurrent Central Nervous System LymphomaRefractory Central Nervous System Lymphoma M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Ended earlyNCT06088654What this trial is testingPhase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin LymphomaWho this might be right forNon Hodgkin Lymphoma Innate Pharma 23
Early research (Phase 1)Active Not RecruitingNCT05665062What this trial is testingAutologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic MalignanciesWho this might be right forCLL/SLLNHLMantle Cell Lymphoma+4 more Synthekine 36
Early research (Phase 1)Looking for participantsNCT06334991What this trial is testingStudy for Subjects With Relapsed/Refractory Non-Hodgkin LymphomaWho this might be right forNon-Hodgkin Lymphoma Refractory/ Relapsed ImmunityBio, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT01839916What this trial is testingDonor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more University of Chicago 77
Testing effectiveness (Phase 2)UnknownNCT05871684What this trial is testingA Combination Study of CAR-T Therapy in r/r B-NHLWho this might be right forDiffuse Large B Cell Lymphoma Ruijin Hospital 48
Early research (Phase 1)Study completedNCT02594384What this trial is testingA Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic OrphAI Therapeutics 62
Not applicableStudy completedNCT01233921What this trial is testingPalifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more Martin, Paul 6
Not applicableUnknownNCT05927558What this trial is testingSalvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL StudyWho this might be right forB-cell Non Hodgkin LymphomaRelapseRefractory Lymphoma Gruppo Italiano Malattie EMatologiche dell'Adulto 96
Testing effectiveness (Phase 2)Study completedNCT00436618What this trial is testingEverolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous TreatmentWho this might be right forLeukemiaLymphomaLymphoproliferative Disorder Mayo Clinic 277
Testing effectiveness (Phase 2)Study completedNCT00047021What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or LymphomaWho this might be right forLeukemiaLymphoma Case Comprehensive Cancer Center 3